Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.52 |
| ▸ | HRH1 | P35367 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 2/20 | 0.37 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.37 |
| ▸ | CHUK | O15111 | 1/20 | 0.37 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.37 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.37 |
| ▸ | PHKG2 | P15735 | 1/20 | 0.37 |
| ▸ | PRKACA | P17612 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2569768 | 0.88 | HRH1 (0.52) | LOXL2HRH1CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL17132267 | 0.86 | LOXL2 (0.46) | LOXL2HRH1CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL14101264 | 0.82 | LOXL2 (0.42) | LOXL2HRH1CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL492258 | 0.81 | TSHR (0.52) | LOXL2HRH1CYP3A4CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL27794104 | 0.79 | TSHR (0.50) | LOXL2HRH1CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL10264180 | 0.78 | CYP3A4 (0.41) | LOXL2CYP3A4CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL13736313 | 0.78 | LOXL2 (0.39) | LOXL2CYP3A4CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL2794 | 0.77 | TSHR (0.64) | LOXL2TSHRKDM4E | |
| SCHEMBL10506197 | 0.77 | LOXL2 (0.38) | LOXL2CYP3A4CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL12743794 | 0.77 | HRH1 (0.48) | LOXL2HRH1CYP3A4CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2382274-B1 | AQUEOUS COATING COMPOSITION COMPRISING PYRIDINE GROUP-CONTAINING ELECTROCOAT RESIN | BASF COATINGS GMBH (DE) | 2015-04-22 | — | — | EP | disclosed |
| EP-2382274-A1 | PYRIDINE GROUP-CONTAINING ELECTROCOAT RESIN | BASF Coatings GmbH (DE) | 2011-11-02 | — | — | EP | disclosed |
| WO-2010077404-A1 | PYRIDINE GROUP-CONTAINING ELECTROCOAT RESIN | BASF COATINGS GMBH (US) | 2010-07-08 | — | — | WO | disclosed |
| US-20100167069-A1 | PYRIDINE GROUP-CONTAINING ELECTROCOAT RESIN | BASF CORPORATION (US) | 2010-07-01 | — | — | US | disclosed |
| US-20100167071-A1 | PYRIDINE GROUP-CONTAINING ELECTROCOAT COMPOSITION WITH METAL OXIDE | BASF CORPORATION (US) | 2010-07-01 | — | — | US | disclosed |
| EP-1513524-A4 | ETHER SUBSTITUTED IMIDAZOPYRIDINES | 3M INNOVATIVE PROPERTIES CO (US) | 2008-09-03 | — | — | EP | disclosed |
| US-7220758-B2 | Ether substituted imidazopyridines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-05-22 | — | — | US | disclosed |
| US-20060252792-A1 | ETHER SUBSTITUTED IMIDAZOPYRIDINES | 3M INNOVATIVE PROPERTIES COMPANY | 2006-11-09 | — | — | US | disclosed |
| US-7125890-B2 | Ether substituted imidazopyridines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-10-24 | — | — | US | disclosed |
| EP-1513524-A2 | ETHER SUBSTITUTED IMIDAZOPYRIDINES | 3M Innovative Properties Company (US) | 2005-03-16 | — | — | EP | disclosed |
| US-20050032830-A1 | Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors | 3M INNOVATIVE PROPERTIES COMPANY | 2005-02-10 | — | — | US | disclosed |
| US-6797718-B2 | Ether substituted imidazopyridines | 3M INNOVATIVE PROPERTIES COMPANY | 2004-09-28 | — | — | US | disclosed |
| US-20040010007-A1 | Ether substituted imidazopyridines | 3M INNOVATIVE PROPERTIES COMPANY | 2004-01-15 | — | — | US | disclosed |
| WO-2003103584-A2 | ETHER SUBSTITUTED IMIDAZOPYRIDINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252792-A1 | ETHER SUBSTITUTED IMIDAZOPYRIDINES | IL2, IL4, MYD88 | LOXL2 3894/4885HRH1 984/4885CYP3A4 122/4885 |
| US-20050032830-A1 | Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors | IL2, IFNG, TSLP | LOXL2 3674/4885HRH1 1239/4885CYP3A4 312/4885 |
| US-20040010007-A1 | Ether substituted imidazopyridines | IL2, IL4, MYD88 | LOXL2 3894/4885HRH1 984/4885CYP3A4 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.